Trials

  • September 21, 2017

    Doctor Tearfully Recalls Outbreak In Meningitis Murder Trial

    A doctor who unwittingly injected his patients with mold-contaminated steroids broke down in tears while testifying Thursday in the murder trial of the man accused of making the deadly drugs, giving jurors an inside account of personal and professional devastation five years ago to the month.

  • September 21, 2017

    Teamsters Ask 1st Circ. To Look At Juror's Cagey Call

    Two Boston-area Teamsters who recently had most of their convictions for extorting other union members and local businesses thrown out by the First Circuit asked the court Wednesday to take another crack at their appeal and address their concerns about a juror’s cagey post-verdict voicemail.

  • September 21, 2017

    Ex-Fla. State Rep. Can't Get New Trial On Fraud Charges

    Former Florida House of Representatives member Dwayne L. Taylor won't get a new trial after a federal judge said Wednesday there was ample evidence for the jury to convict him of wire fraud for misusing campaign funds in connection with two recent re-election campaigns.

  • September 21, 2017

    CEO's Oversight Doesn't Merit $1M Tax Penalty, Judge Says

    A Pennsylvania federal judge on Wednesday sided with a pharmaceutical CEO challenging a nearly $1 million tax penalty, ruling after a bench trial that while the executive may have been negligent when he failed to disclose a Swiss bank account, he didn’t willfully violate an IRS reporting requirement.

  • September 21, 2017

    No New Trial For Commodities Pool Chief In Fraud Case

    An Illinois federal judge refused Wednesday to grant a new trial for a Nebraska-based commodities pool operator found liable for fraud by a jury, and granted a highly dialed-back version of the monetary punishment requested by the Commodity Futures Trading Commission.

  • September 21, 2017

    Feds Fight Shkreli Bid To Release $5M In Bail Funds

    Brooklyn federal prosecutors pushed back Wednesday against a request by Martin Shkreli to get his hands on his $5 million bail following the controversial former pharmaceutical executive’s remand to custody, saying the funds should be held to satisfy potential financial penalties he faces at sentencing.

  • September 20, 2017

    Patent For Cholesterol Drug Livalo Is Valid, Judge Rules

    Japanese drugmaker Kowa Co. Ltd. won a patent infringement trial against Amneal and Apotex on Wednesday when a New York federal judge delivered the verdict that Kowa’s patent for the statin Livalo was valid and that the defendants were not able to show it was anticipated or obvious.

  • September 20, 2017

    Pathogen-Killer Claims Unfair, Medical Co. CEO Testifies

    Medical garment maker Vestagen Protective Technologies has gained an unfair market advantage by making false and unlawful claims that its products kill 99 percent of all pathogens, the CEO for rival Strategic Partners testified Wednesday in a California federal trial where his company is defending against theft of trade secret claims.

  • September 20, 2017

    New Trial Granted In DePuy Hip Replacement Litigation

    A woman who lost a hip replacement negligence case against DePuy Orthopaedics was granted a new trial Tuesday when an Illinois judge ruled the testimony of a joint replacement researcher had been unfairly barred from the original trial.

  • September 20, 2017

    Ex-Raytheon Engineer's Wrongful Termination Heads To Trial

    A former engineer for Raytheon Co. told a California federal jury Wednesday that the defense contractor fired him from his six-figure job as retaliation for blowing the whistle about alleged "timecard fraud" on government jobs.

  • September 20, 2017

    ACLU Urges Mass. Justices To Toss Tainted Drug Convictions

    The American Civil Liberties Union of Massachusetts on Wednesday urged the state’s highest court to throw out thousands of convictions tainted by a chemist who admitted to consuming meth, ketamine and other drugs while on the job.

  • September 20, 2017

    FBI Agent Says Menendez Did Not Disclose Doctor's Gifts

    Sen. Bob Menendez did not report the private jet rides and other gifts provided to him by a Florida ophthalmologist on annual financial disclosure forms as part of what prosecutors say was an effort to conceal their bribery scheme, according to testimony Wednesday at the senator's and doctor's trial.

  • September 20, 2017

    Maron Marvel Extends Footprint To Chicago, St. Louis

    Delaware-based Maron Marvel Bradley Anderson & Tardy LLC has expanded to Illinois and Missouri, the firm announced this week, continuing its focus on litigation in the areas of mass toxic tort, products liability, personal injury and environmental regulation.

  • September 20, 2017

    Gore Can't Slip Invalidity Verdict In Stent Patent Row

    A Delaware federal judge on Wednesday denied W.L. Gore & Associates Inc.’s bid to toss a jury’s finding that Gore’s patent relating to a stent device, which Gore had unsuccessfully alleged was infringed by C.R. Bard Inc., is invalid over prior art.

  • September 20, 2017

    Xarelto Bellwether Loser Says New Study Merits Retrial

    A woman who lost a federal bellwether trial on claims that Janssen Pharmaceuticals’ and Bayer’s blood thinner Xarelto caused her hospitalization for internal bleeding has moved for a new trial, arguing jurors should see a recent study by Bayer scientists that contradicts the companies’ trial testimony.

  • September 20, 2017

    4th Bellwether Over J&J Metal Hip Implants Kicks Off

    Six plaintiffs on Wednesday told a Texas federal jury that a money-driven Johnson & Johnson pushed a dangerous metal-on-metal hip implant into the world that it knew wouldn’t work well and that was defectively manufactured, in the fourth bellwether trial in multidistrict litigation over the devices.

  • September 20, 2017

    Feds Say Platinum Fund Downfall Plays Into Union Graft Case

    Manhattan federal prosecutors on Tuesday said a jury deciding if Platinum Partners LP's founder bribed a union official for investments should hear evidence that Platinum's principal fund was losing investors at the time.

  • September 20, 2017

    Leak Suspect Seeks Release Pending Trial

    A former government contractor accused of leaking classified information to a media outlet asked a Georgia federal judge Tuesday to reconsider her request for release on bail while she awaits her criminal trial, saying newly available facts support her request for conditional surrender.

  • September 20, 2017

    The Road To Cox's 10th Circ. Win In Set-Top Box Tying Case

    The Tenth Circuit on Tuesday affirmed the defeat of a $6.3 million verdict against Cox Communications Inc. in litigation accusing the company of tying its premium cable services to rentals of its set-top boxes, the latest development in a serpentine proceeding that has stretched longer than eight years. Here, Law360 runs down some of the milestones in the proceedings.

  • September 20, 2017

    Meningitis Murder Trial Dogged By Accusations Jurors Misled

    Prosecutors and defense attorneys accused one another of misleading a jury in opening statements of the second meningitis murder trial Tuesday, with both sides asking the judge to tell jurors the other lawyers were wrong.

Expert Analysis

  • Series

    What I Learned In My 1st Year: Never Give Up

    Alan Hoffman

    In my first week of practice, I was assigned to litigation that had been pending for 17 years. No discovery had been done, and the case was set for trial or dismissal in less than 60 days. From what followed, I learned some of the most important lessons of my career, says Alan Hoffman of Husch Blackwell LLP.

  • When Plaintiffs Sue Over Products They Did Not Purchase

    Francis Citera

    The Northern District of Illinois has recently allowed plaintiffs to allege standing for products they did not purchase in two different cases. But the key common element is that the products the plaintiffs did purchase and those they did not were substantially similar, says Francis Citera of Greenberg Traurig LLP.

  • Charting A Course To Business Judgment Review

    Stacy Nettleton

    The Delaware Chancery Court’s recent decision to dismiss a shareholder suit challenging the sale of Martha Stewart Living Omnimedia confirms that there is a path to business judgment rule review, at the pleading stage, of third-party mergers of controlled companies where disparate consideration creates a conflict for the controlling stockholder, say Stacy Nettleton and Christie Di Guglielmo of Weil Gotshal & Manges LLP.

  • Supreme Court Applied 'Settled Principles' In BMS Ruling

    Leslie Brueckner

    The U.S. Supreme Court’s recent ruling in Bristol-Myers Squibb v. Superior Court has been characterized by some in the defense bar as portending a sea change in specific personal jurisdiction. But the case did not move the legal needle as far as the defense bar had hoped, say Leslie Brueckner of Public Justice and Andre Mura of Gibbs Law Group LLP.

  • A Common Thread In California 'Organic' Textile Lawsuits

    Teresa Michaud

    Recent cases filed against manufacturers and retailers of “organic” textile products in California originate with a nonprofit group, and pose a risk to firms selling certain goods in California that are labeled as organic but that fall short of certain state standards, say Teresa Michaud and Anne Kelts of Baker McKenzie.

  • How Collaboration Is Changing Inside Some Law Firms

    Chris Cartrett

    In our recent survey of business of law professionals, nearly half of respondents said that who they collaborate with, inside their law firm, is different from five years ago, says Chris Cartrett of legal software provider Aderant.

  • Welcome To Wilmington: What Patent Lawyers Need To Know

    Sherry Salmons

    While Wilmington, Delaware, is generally a pro-plaintiffs venue, there are also avenues by which corporate defendants can gain significant traction in this town, says Sherry Salmons of Salmons Communications Consulting.

  • Opinion

    Dealing With Difficult Lawyers

    Alan Hoffman

    Some lawyers tend to be overly aggressive, regarding law practice as a zero-sum game in which there are only winners and losers. The best response is to act professionally — separating the matter at hand from the personalities. But it is also important to show resolve and not be vulnerable to intimidation, says Alan Hoffman of Husch Blackwell LLP.

  • Unlisted Food Ingredients: A Recipe For Trouble

    Jack Nolan

    The Middle District of Tennessee recently denied Whole Foods’ motion to dismiss a complaint concerning a slice of pizza containing undisclosed pecans consumed by a child with a severe nut allergy. Warnings may be required when an ingredient is something to which a “substantial number of persons” are allergic, says Jack Nolan of Weil Gotshal & Manges LLP.

  • Shkreli Trial And Other Magic Tricks: A Chat With Ben Brafman

    Randy Maniloff

    Ben Brafman’s clients don’t need a lawyer — they need a magician. And for 40-plus years, the man has been pulling rabbits out of hats, most recently finding jurors able to sit fairly in judgment of Martin Shkreli, called “the most hated man in America.” Last month I visited Brafman to discuss his remarkable career, says Randy Maniloff of White and Williams.